Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
latanoprost/dorzolamide (CKD-351) / Chong Kun Dang
NCT04448223: A Clinical Study to Evaluate the Efficacy and Safety of CKD-351	Recruiting	2	100	RoW	CKD-351, Latanoprost+Dorzolmamide	Chong Kun Dang Pharmaceutical	Primary Open Angle Glaucoma, Ocular Hypertension	12/22	12/22